Odyssey voyages to Nasdaq with $304M IPO to fund autoimmune, inflammatory pipeline

Endpoints News'Pharma, not really’: Top young AI talent shuns careers at big drugmakers

PharmaVoiceBiotech layoffs are easing, but is the worst over?

Thermo FisherThermo Fisher’s New Cell Therapy Bioreactor And Bioprocess Hub Might Change The Case For Investing In TMO - simplywall.st

AgilentDna Forensic Market Is Booming So Rapidly | Agilent Technologies, Illumina, Bio-Rad Laboratories - openPR.com

AgilentSwedbank AB Raises Holdings in Agilent Technologies, Inc. $A - MarketBeat

10x Genomics BlogDeutsche Bank Adjusts 10x Genomics Price Target to $23 From $17, Maintains Hold Rating - marketscreener.com

FierceBiotechOdyssey voyages to Nasdaq with $304M IPO to fund autoimmune, inflammatory pipeline

LabiotechThe biggest biotech funding rounds in April 2026

Endpoints NewsNatalie Holles' next move after Third Harmonic shutdown; Mark Alles passes the torch at ADC biotech

Endpoints NewsCapricor sues Nippon Shinyaku over Duchenne drug 'pricing flaw' and launch prep

Lonza NewsLonza Says Big Pharma Might Delay Outsourcing Decisions Amid U.S. Investments - WSJ

Science Daily BiotechWhat scientists found inside coral reefs could change the future of medicine